Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $2.78 billion. The enterprise value is $1.96 billion.

Market Cap	2.78B
Enterprise Value	1.96B

Important Dates

The next estimated earnings date is Monday, August 26, 2024, before market open.

Earnings Date	Aug 26, 2024
Ex-Dividend Date	n/a

Share Statistics

APGE has 58.46 million shares outstanding. The number of shares has increased by 903.80% in one year.

Shares Outstanding	58.46M
Shares Change (YoY)	+903.80%
Shares Change (QoQ)	+100.71%
Owned by Insiders (%)	11.59%
Owned by Institutions (%)	106.43%
Float	29.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.46
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.08, with a Debt / Equity ratio of 0.00.

Current Ratio	38.08
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.10% and return on invested capital (ROIC) is -14.76%.

Return on Equity (ROE)	-27.10%
Return on Assets (ROA)	-23.20%
Return on Capital (ROIC)	-14.76%
Revenue Per Employee	n/a
Profits Per Employee	-$11.51M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +132.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+132.27%
50-Day Moving Average	44.81
200-Day Moving Average	37.88
Relative Strength Index (RSI)	60.35
Average Volume (20 Days)	575,922

Short Selling Information

The latest short interest is 7.94 million, so 13.59% of the outstanding shares have been sold short.

Short Interest	7.94M
Short Previous Month	6.73M
Short % of Shares Out	13.59%
Short % of Float	27.05%
Short Ratio (days to cover)	15.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-118.53M
Pretax Income	-103.55M
Net Income	-103.55M
EBITDA	-103.17M
EBIT	-103.55M
Earnings Per Share (EPS)	-$5.25

Full Income Statement

Balance Sheet

The company has $816.20 million in cash and $1.77 million in debt, giving a net cash position of $814.43 million or $13.93 per share.

Cash & Cash Equivalents	816.20M
Total Debt	1.77M
Net Cash	814.43M
Net Cash Per Share	$13.93
Equity (Book Value)	801.48M
Book Value Per Share	13.71
Working Capital	799.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$95.84 million and capital expenditures -$518,000, giving a free cash flow of -$96.36 million.

Operating Cash Flow	-95.84M
Capital Expenditures	-518,000
Free Cash Flow	-96.36M
FCF Per Share	-$1.92

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-903.80%
Shareholder Yield	-903.80%
Earnings Yield	-3.73%
FCF Yield	-3.47%

Analyst Forecast

The average price target for APGE is $65.80, which is 38.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$65.80
Price Target Difference	38.53%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	1.90%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2